ATE145405T1 - Cholecystokinin-antagonisten - Google Patents

Cholecystokinin-antagonisten

Info

Publication number
ATE145405T1
ATE145405T1 AT90912437T AT90912437T ATE145405T1 AT E145405 T1 ATE145405 T1 AT E145405T1 AT 90912437 T AT90912437 T AT 90912437T AT 90912437 T AT90912437 T AT 90912437T AT E145405 T1 ATE145405 T1 AT E145405T1
Authority
AT
Austria
Prior art keywords
inclusive
carbon atoms
group
alkyl group
hydroxy
Prior art date
Application number
AT90912437T
Other languages
English (en)
Inventor
Sun Hyuk Kim
Sylviane Moreau
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Application granted granted Critical
Publication of ATE145405T1 publication Critical patent/ATE145405T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90912437T 1989-08-21 1990-08-20 Cholecystokinin-antagonisten ATE145405T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/396,567 US5010089A (en) 1988-08-12 1989-08-21 CCK antagonists and their use in treating gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE145405T1 true ATE145405T1 (de) 1996-12-15

Family

ID=23567756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912437T ATE145405T1 (de) 1989-08-21 1990-08-20 Cholecystokinin-antagonisten

Country Status (13)

Country Link
US (1) US5010089A (de)
EP (1) EP0489767B1 (de)
JP (1) JPH05500049A (de)
AT (1) ATE145405T1 (de)
CA (1) CA2064897A1 (de)
DE (1) DE69029198T2 (de)
DK (1) DK0489767T3 (de)
ES (1) ES2095878T3 (de)
GR (1) GR1001001B (de)
IE (1) IE903009A1 (de)
NO (1) NO920677L (de)
PT (1) PT95059B (de)
WO (1) WO1991002719A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
WO1995024389A1 (en) * 1994-03-10 1995-09-14 Warner-Lambert Company Indole derivatives as cck receptor antagonists
CA2224062C (en) * 1995-06-06 2001-09-04 Pfizer Limited Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
KR100241643B1 (ko) 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
FI974437A7 (fi) 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics
US4757151A (en) * 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US4803284A (en) * 1987-08-19 1989-02-07 Centro De Investigacion Y De Estudios Avanzados Del Instituto Politecnico Nacional Processes for the preparation of 3-amino-2-(5-methoxy-1H-indol-3-yl) propionic acid monohydrate

Also Published As

Publication number Publication date
NO920677D0 (no) 1992-02-20
DE69029198T2 (de) 1997-04-24
GR900100625A (en) 1991-12-30
EP0489767A4 (en) 1992-07-08
DK0489767T3 (da) 1996-12-09
PT95059A (pt) 1991-05-22
ES2095878T3 (es) 1997-03-01
DE69029198D1 (de) 1997-01-02
IE903009A1 (en) 1991-02-27
PT95059B (pt) 1997-12-31
US5010089A (en) 1991-04-23
EP0489767B1 (de) 1996-11-20
WO1991002719A3 (en) 1991-04-04
NO920677L (no) 1992-04-07
JPH05500049A (ja) 1993-01-14
WO1991002719A2 (en) 1991-03-07
CA2064897A1 (en) 1991-02-22
EP0489767A1 (de) 1992-06-17
GR1001001B (el) 1993-03-31

Similar Documents

Publication Publication Date Title
PT776324E (pt) Antagonista da endotelina
NO930817L (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
DE3650315D1 (de) Cyancrotonsäureamidverbindung als Arzneimittel mit immunmodulierenden Eigenschaften.
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
DE69525354D1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
ATE154021T1 (de) N-cyclohexyl benzamide derivate, ihre herstellungen und therapeutischen anwendungen
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
NO952743D0 (no) Ny benzotiadiazinforbindelse, dens fremstilling og farmasöytiske preparater
DE69029198D1 (de) Cholecystokinin-antagonisten
DK484787A (da) Bis-dioxopiperazin-derivater
PT84136B (pt) Processo para a preparacao de derivados de pirrolo {1,2-a} {4,1} benzoxazepina
ES2072897T3 (es) Un metodo para producir y sintetizar una composicion farmaceutica y su uso.
GR3017951T3 (en) Methylpiperazinoazepine derivatives, their preparation and use.
NO870251L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
ES2077985T3 (es) Inhibidores de la acil-coa: colesterol-acil transferasa, a base de 5-bis-aminometilen-1,3-dioxano-4,6-diona n,n',n'-trisubstituida.
ES510653A0 (es) "procedimiento para la preparacion de n-(2,6-diclorofenil)-acetamidina".
ECSP910725A (es) Procedimiento para preparar nuevos derivados de 4( 1h) quinolona

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee